Growth Metrics

OptimizeRx (OPRX) Receivables Refunds (2023 - 2025)

OptimizeRx's Receivables Refunds history spans 3 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Receivables Refunds rose 2629.69% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, up 2629.69%, while the annual FY2023 figure was $1.0 million, N/A changed from the prior year.
  • Receivables Refunds for Q3 2025 was $1.7 million at OptimizeRx, up from $646000.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $1.8 million in Q2 2024 and bottomed at $64000.0 in Q3 2024.
  • The 3-year median for Receivables Refunds is $1.0 million (2023), against an average of $926285.7.
  • The largest YoY upside for Receivables Refunds was 2629.69% in 2025 against a maximum downside of 89.09% in 2025.
  • A 3-year view of Receivables Refunds shows it stood at $1.0 million in 2023, then plummeted by 93.82% to $64000.0 in 2024, then skyrocketed by 2629.69% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Receivables Refunds are $1.7 million (Q3 2025), $646000.0 (Q2 2025), and $113000.0 (Q1 2025).